Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Promising HPV Test: Fast, Precise and Low-Cost

09.02.2006


Researchers at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in the group of Markus Schmitt have developed a detection method for human papillomaviruses (HPV) which allows them to identify, in a quick and highly reliable manner, high-risk viruses that cause cervical cancer.



The prime risk factor for cervical cancer is an infection with human papillomaviruses. However, not all HPV types are a health hazard. Scientists distinguish between high-risk types and more harmless family members. There are detection methods available that basically allow one to precisely identify the virus type. However, current methods are not really suitable for large-scale use. In addition, it is not possible to unambiguously detect multiple infections with several different virus types.

An approach developed by virus researchers of the German Cancer Research Center now provides a promising alternative. Markus Schmitt and his colleagues describe their test method in the latest issue of the Journal of Clinical Microbiology*: They first isolate the viral genetic material from a tissue sample, amplify and label it. The enriched DNA material is subsequently mixed with different probes, i.e. small DNA fragments each of which is typical for a specific virus type. If the DNA sequences of the viral DNA under study and the probe are identical, they will bind to each other. The probe thus isolates the unknown DNA from the mixture – a process called hybridization. The probes, in turn, are coupled to tiny plastic beads of different colors, with each type of probe attached to beads of the same color. A reading device measures the amount of hybridized viral DNA on the beads. By their characteristic color, the beads tell us which viral DNA was present in the sample.


Schmitt and his colleagues have developed 22 highly sensitive probes which even make it possible to distinguish HPV types whose genomes vary ever so slightly. In addition, a “universal” probe facilitates detection of yet unknown HPV types. The researchers found out that the genotyping is in no way inferior to previous, more complex investigation methods. It is even more sensitive (a minimum of six different virus types can be detected in one sample) and less error-prone (the results are reproducible at any time). These are excellent prerequisites for using the test as a high-throughput method.

The enriched DNA material from 500 tissue samples can be tested for up to 100 HPV types – all in just one day. Since the test can be performed with relatively little effort and at low costs it is suitable for use in large-scale population studies to investigate distribution, variety and infection behavior of the cancer causing viruses. Moreover, the detection method can help to better assess the effectiveness of a vaccination against the virus. Finally, virus typing would be a useful supplement in routine diagnostics. Particularly women with chronic high-risk HPV infection might benefit from a combination of the new HPV test and a Pap smear, which is part of early cancer diagnosis measures covered by the statutory health insurance.

Cervical cancer is the second most frequent cancer among women worldwide. For 2002, an estimated 493,000 new cases were expected and more than 273,000 women died of cervical cancer in the same year (International Agency for Research on Cancer). The Robert Koch Institute estimated in 2000 that slightly over 6,500 women are newly diagnosed with the disease each year in Germany. The tumor usually develops slowly; precancerous changes are diagnosed in about 50% of cases. If detected early, cervical cancer can be treated and cured without difficulty.

The task of the Deutsches Krebsforschungszentrum in Heidelberg (German Cancer Research Center, DKFZ) is to systematically investigate the mechanisms of cancer development and to identify cancer risk factors. The results of this basic research are expected to lead to new approaches in the prevention, diagnosis and treatment of cancer. The Center is financed to 90 percent by the Federal Ministry of Education and Research and to 10 percent by the State of Baden-Wuerttemberg. It is a member of the Helmholtz Association of National Research Centers (Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V., HGF).

Julia Rautenstrauch | alfa
Further information:
http://www.dkfz.de

More articles from Health and Medicine:

nachricht 'Icebreaker' protein opens genome for t cell development, Penn researchers find
21.02.2018 | University of Pennsylvania School of Medicine

nachricht Similarities found in cancer initiation in kidney, liver, stomach, pancreas
21.02.2018 | Washington University School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Researchers invent tiny, light-powered wires to modulate brain's electrical signals

21.02.2018 | Life Sciences

The “Holy Grail” of peptide chemistry: Making peptide active agents available orally

21.02.2018 | Life Sciences

Atomic structure of ultrasound material not what anyone expected

21.02.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>